Schedule of consolidated financial statements the related party transactions (Details) - Alps Life Science Inc [Member] - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|||
| Director [Member] | ||||
| IfrsStatementLineItems [Line Items] | ||||
| Agent commission | $ 45,590 | $ 18,102 | ||
| Consultancy fee | 51,663 | |||
| Patent License Agreement | [1] | 707,028 | ||
| Alps Globemedics Sdn Bhd [member] | ||||
| IfrsStatementLineItems [Line Items] | ||||
| Agent commission | 196,531 | 120,189 | ||
| Management fee income | $ 13,534 | $ 12,916 | ||
| ||||